SEARCH RESULTS FOR: "Tag: HRTX"
REFINE YOUR SEARCH:
ARTICLES/BLOGS
2019(2)
2018(5)
2017(2)
2016(5)
2015(10)
CATEGORIES
Analyst Downgrades(1)
Analyst Update(3)
Analyst Upgrades(3)
Best and Worst Stocks(1)
Buzz Stocks(2)
By the Numbers(1)
Editor's Pick(1)
Ezines(2)
Intraday Option Activity(3)
Investor Sentiment(1)
Market Recap(1)
Midday Market Check(3)
Opening View(1)
Quantitative Analysis(3)
Stock Market News(1)
Stocks On the Move(4)
Technical Analysis(2)

5/1/2019 1:46 PM
The shares of Pacira Biosciences Inc (NASDAQ:PCRX) gapped higher this morning, after rival Heron Therapeutics (HRTX) said the Food and Drug Administration (FDA) declined to approve its post-operati...
5/1/2019 10:02 AM
Near the bottom of the Nasdaq morning sits Heron Therapeutics Inc (NASDAQ:HRTX), down 21% to trade at $17.44 this morning, and earlier fell to a new annual low of $16.20. The Food and Drug Administrat...
12/31/2018 3:24 PM
Stocks are trading higher in the last day of 2018. While the pre-holiday session has been mostly quiet, automaker Tesla Inc (NASDAQ:TSLA), healthcare issue Heron Therapeutics Inc (NASDAQ:HRTX), and...
6/21/2018 3:31 PM
Stocks are continuing their downward spiral this afternoon, with focus shifting to today's Supreme Court ruling that says online sales can now be taxed by states. Three individual stocks making note...
4/26/2018 2:28 PM
Biotech name Heron Therapeutics Inc (NASDAQ:HRTX) once again appeared on Schaeffer's Senior Quantitative Analyst Rocky White's list of stocks that are currently trading near a 52-week high, but also s...

Welcome to Schaeffer's Investment Research! We are a privately held provider of stock and options trading recommendations, options education, and market commentary, headquartered in Cincinnati, Ohio. Founded in 1981 by industry pioneer Bernie Schaeffer, we've since become a trusted source of research and analysis for individual investors and major financial media outlets alike.







Partner Center